Priority 4 from the Psoriasis PSP
|UNCERTAINTY: What is the best way to treat the symptoms of psoriasis: itching, burning, redness, scaling and flaking? (JLA PSP Priority 4)
|JLA question ID
|Not available for this PSP
Shahwan Evidence of no significant difference in mean baseline itch scores in patients with psoriasis or atopic dermatitis who need treatment with systemic therapies. Evidence that pruritus is a more significant component of psoriasis than previously recognised. Pruritus in psoriasis has been associated with occupational impairment, anxiety, depression, and has a negative impact on overall quality of life, mood, concentration, sleep, sexual desire, and appetite. Further research is needed.
Van Laarhoven Evidence that placebo can have a substantial effect in the treatment of itch in dermatological patients with chronic itch due to a variety of skin diseases including psoriasis. Further research needed.
|Health Research Classification System category
|Extra information provided by this PSP
|Original uncertainty examples
|How can itching be controlled properly?
|54 uncertainties were submitted around this question
|PSP unique ID
|Total number of uncertainties identified by this PSP.
|55 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
|Date of priority setting workshop
|17 September 2018